Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.52% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.51% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Renasant Corp
RNST
$4B
| $1.95M | ﹤0.01% |
89,200
| – | – |
|
1477
Schneider National
SNDR
$6.37B
| $1.94M | ﹤0.01% |
100,400
+1,400
| +1% | +$29K |
|
1478
Axos Financial
AX
$5.72B
| $1.94M | ﹤0.01% |
107,000
+1,600
| +2% | +$40.2K |
|
|
HTLF
1479
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.94M | ﹤0.01% |
64,100
+900
| +1% | +$39.4K |
|
1480
Lindsay Corp
LNN
$1.17B
| $1.92M | ﹤0.01% |
21,000
+400
| +2% | +$39.4K |
|
|
PVG
1481
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.92M | ﹤0.01% |
342,648
+5,900
| +2% | +$50.4K |
|
1482
Atkore
ATKR
$3.17B
| $1.92M | ﹤0.01% |
91,100
+2,000
| +2% | +$71.7K |
|
1483
CNX Resources
CNX
$5.23B
| $1.92M | ﹤0.01% |
360,158
| – | – |
|
|
TRHC
1484
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.91M | ﹤0.01% |
36,600
+700
| +2% | +$37.9K |
|
|
GTLS
1485
DELISTED
Chart Industries
GTLS
| $1.91M | ﹤0.01% |
66,000
+900
| +1% | +$48.9K |
|
1486
Palomar
PLMR
$3.37B
| $1.91M | ﹤0.01% |
32,800
+11,100
| +51% | +$580K |
|
1487
Theravance Biopharma
TBPH
$878M
| $1.91M | ﹤0.01% |
82,542
+1,200
| +1% | +$30K |
|
1488
Equinox Gold
EQX
$13.1B
| $1.91M | ﹤0.01% |
+290,528
| New | +$2.29M |
|
1489
Pediatrix Medical
MD
$2.14B
| $1.9M | ﹤0.01% |
163,500
+2,300
| +1% | +$47.4K |
|
1490
Methode Electronics
MEI
$593M
| $1.9M | ﹤0.01% |
71,900
+900
| +1% | +$29.3K |
|
1491
Southside Bancshares
SBSI
$984M
| $1.89M | ﹤0.01% |
62,218
+900
| +1% | +$30.4K |
|
|
CSW
1492
CSW Industrials
CSW
$5.59B
| $1.89M | ﹤0.01% |
29,149
+400
| +1% | +$29K |
|
1493
Strategy Inc
MSTR
$38.2B
| $1.89M | ﹤0.01% |
160,000
+3,000
| +2% | +$40.7K |
|
1494
Eldorado Gold
EGO
$10B
| $1.89M | ﹤0.01% |
309,020
+4,100
| +1% | +$30.9K |
|
|
ATRI
1495
DELISTED
Atrion Corp
ATRI
| $1.89M | ﹤0.01% |
2,902
+100
| +4% | +$68.3K |
|
1496
Plains GP Holdings
PAGP
$5.04B
| $1.88M | ﹤0.01% |
335,334
+3,134
| +0.9% | +$44.1K |
|
1497
Inogen
INGN
$154M
| $1.88M | ﹤0.01% |
36,300
+700
| +2% | +$33.6K |
|
|
PMT
1498
PennyMac Mortgage Investment
PMT
$828M
| $1.87M | ﹤0.01% |
176,500
+8,400
| +5% | +$166K |
|
1499
Tompkins Financial
TMP
$1.45B
| $1.87M | ﹤0.01% |
26,100
+200
| +0.8% | +$16.6K |
|
1500
Karyopharm Therapeutics
KPTI
$45.1M
| $1.87M | ﹤0.01% |
6,497
+180
| +3% | +$49.7K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.